Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
28 February 2023 | Story Lunga Luthuli and Nonsindiso Qwabe | Photo Sonia Small
Prof Francis Petersen
University of the Free State Rector and Vice-Chancellor, Prof Francis Petersen, addressing first-entry first-year students at this year’s official welcoming and Dream Walk event hosted on the Bloemfontein and Qwaqwa campuses.

‘Welcome to the Kovsie Land. This is the university of your future.’ These words reverberated across the University of the Free State’s (UFS) two campuses as Rector and Vice-Chancellor, Prof Francis Petersen, welcomed first-year students to the beginning of their journey to success.

During the annual official welcoming and the second Dream Walk, known as Kovsie Dream, the UFS welcomed first-year students to the university community on the Bloemfontein and Qwaqwa Campuses over two weekends, emphasizing clarity and the committed pursuit of their dreams and aspirations. 

University, a step towards harnessing personal development

“University is a valuable stage of growth in your life and an important platform for you to mature and gain personal success. It is a meaningful day marking a new chapter in your life,” said Prof Petersen.

The First-Year welcoming event is an important day on the university’s calendar, and the Division of Student Affairs has pulled out all the stops to ensure that, as one of the most memorable and significant days of the student’s academic journey, it was marked with fanfare and the instilling of the Kovsie spirit and values. 

Prof Petersen committed the university to walking the journey with students to see them leave the institution as proud and thriving graduates and UFS alumni.

“Today you stand on the shoulders of many alumni who continue to excel in various fields, not only in South Africa, but on the continent and globally, such as 2016 Olympics gold medallist, Wayde van Niekerk, 2020 Paralympics silver medal winner, Louzanne Coetzee, Free State Cheetahs rugby star, Oupa Mohoje, and former Miss World, Rolene Strauss. The challenge I would like you to sign up for, is to promise yourself, your family, and the UFS that you will develop yourself and try to make society a better place,” added Prof Petersen.

He said: “As you begin your journey as Kovsies, I believe you will forge your path of excellence and expand your potential within the faculties that will be your primary academic home. At the University of the Free State, we inspire excellence and transform lives.”

Qwaqwa Campus dreamwalk

The University of the Free State management leading first-year students on the Qwaqwa Campus during the
Dream Walk, which also provided an opportunity to complete their dream cards, setting their goals and
future aspirations. (Photo: Sonia Small) 


Get set, dream and achieve your goals

From the Callie Human and Mandela Halls respectively, the students participated in a Dream Walk, grouped according to their colleges, having completed dream cards that set goals for their future. In a move to shape the future of student life on the Qwaqwa Campus, on- and off-campus students were incorporated into colleges. This is another fulfilment of the university’s mission to see all students participating fully in student activities and having a holistic campus life experience, regardless of where they stay.


In closing, Prof Petersen said: “At the University of the Free State, we are an institution focused on consistently renewing and reimaging ourselves to effectively impact the communities around us. We equip you for global platforms. We believe that the graduates can operate and exhibit themselves on platforms around the globe.”

The welcoming festivities were closed with serenades by Durban-born Afro-pop songstress and songwriter Azana, former UFS LLB student and UFS alumni, and Van Pletzen band. 

Watch the highlights from this year's welcoming:


News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept